A Five-Gene-Pair-Based Prognostic Signature for Predicting the Relapse Risk of Early Stage ER+ Breast Cancer

A Five-Gene-Pair-Based Prognostic Signature for Predicting the Relapse Risk of Early Stage ER+ Breast Cancer

About 20–30% of early-stage breast cancer patients suffer relapses after surgery. To identify such high-risk patients, many signatures have been reported, but they lack robustness in data measured on different platforms. Here, we developed a signature which is robust across multiple profiling platfo...

Full description

Bibliographic Details
Main Authors: Na Li, Hao Cai, Kai Song, You Guo, Qirui Liang, Jiahui Zhang, Rou Chen, Jing Li, Xianlong Wang, Zheng Guo
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-10-01
Series:Frontiers in Genetics
Subjects:
ER+ breast cancer
micro-metastasis
relapse risk
prognosis signature
gene expression
Online Access:https://www.frontiersin.org/articles/10.3389/fgene.2020.566928/full

Internet

https://www.frontiersin.org/articles/10.3389/fgene.2020.566928/full

Similar Items